JP2012515801A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012515801A5 JP2012515801A5 JP2011548230A JP2011548230A JP2012515801A5 JP 2012515801 A5 JP2012515801 A5 JP 2012515801A5 JP 2011548230 A JP2011548230 A JP 2011548230A JP 2011548230 A JP2011548230 A JP 2011548230A JP 2012515801 A5 JP2012515801 A5 JP 2012515801A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutical composition
- composition according
- pterocin
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14738209P | 2009-01-26 | 2009-01-26 | |
| US61/147,382 | 2009-01-26 | ||
| PCT/US2010/022129 WO2010085811A2 (en) | 2009-01-26 | 2010-01-26 | Use of pterosin compounds for treating diabetes and obesity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012515801A JP2012515801A (ja) | 2012-07-12 |
| JP2012515801A5 true JP2012515801A5 (https=) | 2013-03-14 |
| JP5640019B2 JP5640019B2 (ja) | 2014-12-10 |
Family
ID=42354647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011548230A Expired - Fee Related JP5640019B2 (ja) | 2009-01-26 | 2010-01-26 | 糖尿病及び肥満症を治療するためのプテロシン化合物の使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8633252B2 (https=) |
| EP (1) | EP2389171B1 (https=) |
| JP (1) | JP5640019B2 (https=) |
| KR (1) | KR101746867B1 (https=) |
| CN (1) | CN102333528B (https=) |
| AU (1) | AU2010206549B2 (https=) |
| CA (1) | CA2749931C (https=) |
| NZ (1) | NZ594236A (https=) |
| TW (1) | TWI522109B (https=) |
| WO (1) | WO2010085811A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140377386A1 (en) * | 2013-06-19 | 2014-12-25 | Access Business Group International Llc | Plant-based inhibitors of ketohexokinase for the support of weight management |
| CN106831386A (zh) * | 2015-12-04 | 2017-06-13 | 江西中医药大学 | 新型蕨素类化合物在治疗糖尿病的应用 |
| CN105878220B (zh) * | 2016-04-21 | 2019-02-05 | 广州市爱菩新医药科技有限公司 | 倍半萜类化合物在制备防治高血脂药物中的应用 |
| CN107232497A (zh) * | 2017-06-01 | 2017-10-10 | 河北农业大学 | 一种具有降血脂功能的膨化食品及其制备方法 |
| US20220257532A1 (en) * | 2017-06-16 | 2022-08-18 | Korpharm Co., Ltd. | Compositions containing pterosin compound and derivatives thereof active ingredients for prevention or treatment of degenerative brain diseases |
| CN108576355B (zh) * | 2018-03-27 | 2021-11-09 | 百色学院 | 一种蕨菜多糖含片及其制备方法 |
| CN110156738B (zh) * | 2019-06-26 | 2023-01-03 | 中北大学 | 一种伊鲁烷型倍半萜反应中间体及天然产物的全合成方法 |
| KR102767836B1 (ko) * | 2020-12-14 | 2025-02-14 | 주식회사 지에이치팜 | 프테로신 화합물 및 이의 유도체를 유효성분으로 포함하는 pka 관련 질환 예방 또는 치료용 약학적 조성물 |
| KR20260019211A (ko) | 2024-08-01 | 2026-02-10 | 주식회사 지에이치팜 | 프테로신 d의 신규한 합성 방법 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4745104A (en) * | 1985-04-15 | 1988-05-17 | The Regents Of The University Of California | Pseudopterosin and synthetic derivatives thereof |
| US4849410A (en) * | 1985-04-15 | 1989-07-18 | The Regents Of The University Of California | Pseudopterosin and synthetic derivatives thereof |
| JPS63146839A (ja) * | 1986-12-11 | 1988-06-18 | Toa Nenryo Kogyo Kk | プテロシン系化合物を含んで成る制癌剤 |
| JPH02237932A (ja) * | 1989-03-10 | 1990-09-20 | Yokichi Mochizuki | 結石等の治療剤 |
| US5439936A (en) * | 1989-10-03 | 1995-08-08 | The Regents Of The University Of California | Method of treating certain tumors using illudin analogs |
| US5521202A (en) * | 1993-04-07 | 1996-05-28 | Taiho Pharmaceutical Co., Ltd. | Thiazolidine derivatives and pharmaceutical compositions containing the same |
| EP0945438B1 (en) | 1996-12-12 | 2003-03-05 | Banyu Pharmaceutical Co., Ltd. | Pyrazole derivatives |
| FR2777566B1 (fr) * | 1998-04-15 | 2003-02-21 | Synthelabo | Derives d'azacycloalcanes, leur preparation et leur application en therapeutique |
| IL156445A0 (en) * | 2001-01-26 | 2004-01-04 | Schering Corp | Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| AR036237A1 (es) * | 2001-07-27 | 2004-08-25 | Bayer Corp | Derivados del acido indan acetico, intermediarios, y metodo para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento |
| DE10142668A1 (de) * | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von C2-substituierten Indan-1-on-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| DE10142666A1 (de) * | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| US6797287B2 (en) * | 2001-09-25 | 2004-09-28 | Pharmachem Laboratories, Inc. | Phaseolamin compositions and methods for using the same |
| CN101837003B (zh) * | 2002-04-30 | 2013-09-04 | 尤尼根公司 | 作为治疗剂的包含无取代b环类黄酮和黄烷混合物的组合物 |
| AU2003287965A1 (en) * | 2002-10-24 | 2004-05-13 | Carex Sa | Modulation of peroxisome proliferator activated receptors activity |
| JP4594611B2 (ja) * | 2002-11-08 | 2010-12-08 | 武田薬品工業株式会社 | 受容体機能調節剤 |
| AU2003277576A1 (en) * | 2002-11-08 | 2004-06-07 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
| FR2849849B1 (fr) * | 2003-01-13 | 2006-08-04 | Merck Sante Sas | Nouveaux acides carboxyliques et derives pour le traitement et la prevention du diabete et des dyslipemies |
| CA2516710A1 (en) * | 2003-02-26 | 2004-09-10 | Unigen Pharmaceuticals, Inc. | Formulation for use in the prevention and treatment of carbohydrate induced diseases and conditions |
| JP2007510651A (ja) * | 2003-11-04 | 2007-04-26 | メルク エンド カムパニー インコーポレーテッド | 糖尿病の治療又は予防のためのジペプチジルペプチダーゼ−ｉｖ阻害剤としての縮合フェニルアラニン誘導体 |
| US20050143350A1 (en) * | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
| EA011671B1 (ru) * | 2004-06-04 | 2009-04-28 | Арена Фармасьютикалз, Инк. | Замещенные производные арила и гетероарила в качестве модуляторов метаболизма и для профилактики и лечения связанных с ним расстройств |
| JP2008522972A (ja) * | 2004-12-06 | 2008-07-03 | レリアント ファーマスーティカルズ インコーポレイテッド | 脂肪酸エステルを有する安定性フェノフィブラート組成物 |
| FR2880885B1 (fr) * | 2005-01-14 | 2009-01-30 | Merck Sante Soc Par Actions Si | Derives d'acide phenylbenzoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique |
| US20100137397A1 (en) | 2005-02-05 | 2010-06-03 | Astrazeneca Ab | Chemical Compounds |
| WO2007033002A1 (en) * | 2005-09-14 | 2007-03-22 | Amgen Inc. | Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| US20080200458A1 (en) * | 2007-01-18 | 2008-08-21 | Joseph Barbosa | Methods and compositions for the treatment of body composition disorders |
-
2010
- 2010-01-26 KR KR1020117019877A patent/KR101746867B1/ko not_active Expired - Fee Related
- 2010-01-26 EP EP10734012.7A patent/EP2389171B1/en not_active Not-in-force
- 2010-01-26 US US12/694,132 patent/US8633252B2/en not_active Expired - Fee Related
- 2010-01-26 AU AU2010206549A patent/AU2010206549B2/en not_active Ceased
- 2010-01-26 WO PCT/US2010/022129 patent/WO2010085811A2/en not_active Ceased
- 2010-01-26 CA CA2749931A patent/CA2749931C/en not_active Expired - Fee Related
- 2010-01-26 JP JP2011548230A patent/JP5640019B2/ja not_active Expired - Fee Related
- 2010-01-26 NZ NZ594236A patent/NZ594236A/en not_active IP Right Cessation
- 2010-01-26 CN CN2010800054730A patent/CN102333528B/zh not_active Expired - Fee Related
- 2010-01-26 TW TW099102151A patent/TWI522109B/zh not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012515801A5 (https=) | ||
| RU2490250C2 (ru) | Спиросоединения и их фармацевтическое применение | |
| JP2013508279A5 (https=) | ||
| RU2664534C9 (ru) | Пролекарственная форма тенофовира и ее фармацевтические применения | |
| RU2015100901A (ru) | Производные эфира гетероарилкарбоновой кислоты | |
| JP2010523522A5 (https=) | ||
| JP2010514832A5 (https=) | ||
| JP2013534248A5 (https=) | ||
| JP2013519632A5 (https=) | ||
| JP2011528350A5 (https=) | ||
| JP2009530398A5 (https=) | ||
| JP2013545785A5 (https=) | ||
| IL314360A (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
| JP2016503052A5 (https=) | ||
| RU2012145116A (ru) | Фармацевтическая композиция для предупреждения или лечения неалкогольного жирового гепатоза и способ предупреждения или лечения неалкогольного жирового гепатоза с ее использованием | |
| RU2009120534A (ru) | Новые липидные соединения | |
| EA200901573A1 (ru) | Гетероарилзамещенные тиазолы | |
| RU2013147629A (ru) | Соединения для лечения метаболического синдрома | |
| JP2011516511A5 (https=) | ||
| JP2010090149A5 (https=) | ||
| JP2011519360A5 (https=) | ||
| EP3404029A3 (en) | Pyrimido-pyridazinone compounds and methods and use thereof | |
| JP2012523395A5 (https=) | ||
| RU2011145054A (ru) | Кристаллические формы саксаглиптина | |
| US20200093841A1 (en) | Broad Spectrum Antiviral and Methods of Use |